Who Exports Magnesium from India — 669 Suppliers Behind a $361.3M Market
India's magnesium export market is supplied by 669 active exporters who collectively shipped $361.3M across 8,413 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 51.2% market share, followed by CIPLA LIMITED and DR.REDDY'S LABORATORIES LTD. The top 5 suppliers together control 76.1% of total export value, reflecting a concentrated market structure.
Top Magnesium Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading magnesium exporter from India, holding a 51.2% share of the $361.3M market across 8,413 shipments from 669 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, BIOCON PHARMA LIMITED, ANNORA PHARMA PRIVATE LIMITED — collectively control 76.1% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (51.2%), CIPLA LIMITED (17.1%), DR.REDDY'S LABORATORIES LTD (2.8%), BIOCON PHARMA LIMITED (2.6%), ANNORA PHARMA PRIVATE LIMITED (2.4%).
Top Magnesium Exporters from India
Ranked by export value · 669 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTMAGNESIUM OXIDE TABS 400 MG(232 X 25000ESOMAC-40 MUPS [PAC SIZE:3X10X960 PAC=28800 NOS] | $185.0M | 15 | 51.2% |
| 2 | CIPLA LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000NEXPRO 40 TABLET (ESOMEPRAZOLE MAGNESIUMESOMAC 20 MG TABLETS | $61.6M | 7 | 17.1% |
| 3 | DR.REDDY'S LABORATORIES LTD MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $10.3M | 4 | 2.8% |
| 4 | BIOCON PHARMA LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $9.4M | 1 | 2.6% |
| 5 | ANNORA PHARMA PRIVATE LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $8.6M | 1 | 2.4% |
| 6 | STRIDES PHARMA SCIENCE LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $7.8M | 1 | 2.2% |
| 7 | KAUSIKH THERAPEUTICS PRIVATE LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $6.5M | 2 | 1.8% |
| 8 | TORRENT PHARMACEUTICALS LTD MAGNESIUM OXIDE TABS 400 MG(232 X 25000NEXPRO 40 TABLET (ESOMEPRAZOLE MAGNESIUMESOMAC 20 MG TABLETS | $5.6M | 15 | 1.6% |
| 9 | MYLAN LABORATORIES LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $4.6M | 3 | 1.3% |
| 10 | DR REDDYS LABORATORIES LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $3.3M | 1 | 0.9% |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LTD ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTMAGNESIUM OXIDE TABS 400 MG(232 X 25000ESOMAC-40 MUPS [PAC SIZE:3X10X960 PAC=28800 NOS] | $3.1M | 7 | 0.9% |
| 12 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $3.1M | 1 | 0.9% |
| 13 | ZYDUS LIFESCIENCES LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000NEXPRO 40 TABLET (ESOMEPRAZOLE MAGNESIUMESOMAC 20 MG TABLETS | $2.9M | 2 | 0.8% |
| 14 | GLAND PHARMA LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $2.7M | 1 | 0.8% |
| 15 | AMNEAL INJECTABLES PRIVATE LIMITED MAGNESIUM OXIDE TABS 400 MG(232 X 25000 | $2.6M | 1 | 0.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Magnesium exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Approved | Yes | Yes | Multiple | Sun Pharma is a leading Indian pharmaceutical company with multiple FDA approval |
| Cipla Limited | Approved | Yes | Yes | Multiple | Cipla is a prominent Indian pharmaceutical firm with numerous FDA approvals and |
| Dr. Reddy's Laboratories Ltd | Approved | Yes | Yes | Multiple | Dr. Reddy's Laboratories is a major Indian pharmaceutical company with several F |
| Torrent Pharmaceuticals Ltd | Approved | Yes | Yes | Multiple | Torrent Pharmaceuticals is a significant Indian pharmaceutical company with mult |
| Mylan Laboratories Limited | Approved | Yes | Yes | Multiple | Mylan Laboratories is a global pharmaceutical company with numerous FDA approval |
| Biocon Pharma Limited | Approved | Yes | Yes | Multiple | Biocon Pharma is a leading Indian pharmaceutical company with several FDA approv |
| Strides Pharma Science Limited | Approved | Yes | Yes | Multiple | Strides Pharma Science is a notable Indian pharmaceutical company with multiple |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | Zydus Lifesciences is a prominent Indian pharmaceutical company with numerous FD |
| Gland Pharma Limited | Approved | Yes | Yes | Multiple | Gland Pharma is a significant Indian pharmaceutical company with several FDA app |
| Amneal Pharmaceuticals Private Limited | Approved | Yes | Yes | Multiple | Amneal Pharmaceuticals is a global pharmaceutical company with multiple FDA appr |
TransData Nexus reviewed the regulatory standing of 10 leading Magnesium exporters from India. 10 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Magnesium sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of active pharmaceutical ingredients (APIs). The city hosts numerous pharmaceutical companies specializing in the synthesis of APIs, including magnesium-based compounds. The presence of well-established infrastructure and a skilled workforce contributes to Hyderabad's prominence in bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies in this region excel in developing and producing finished dosage forms, such as tablets and capsules, that incorporate APIs into consumable medications. This specialization ensures that magnesium-based APIs are effectively transformed into market-ready pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical industry. With its proximity to major ports and well-developed logistics infrastructure, this cluster facilitates the efficient export of pharmaceutical products, including those containing magnesium compounds, to international markets. The region's strategic location enhances India's position as a leading exporter of generic medicines.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives and supportive government policies. This cluster attracts numerous pharmaceutical companies, contributing to the production and distribution of a wide range of pharmaceutical products, including those with magnesium components.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supply chain disruptions, consider sourcing magnesium-based APIs and formulations from multiple clusters, including Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the logistical advantages of the Mumbai-Thane-Raigad region to streamline the export process and ensure timely delivery to international markets.
- Explore Tax Benefits: Assess the financial advantages of sourcing from the Baddi-Nalagarh cluster, where tax incentives may offer cost savings in the procurement of pharmaceutical products.
- Monitor Regulatory Compliance: Ensure that all suppliers adhere to the regulatory standards set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and compliance.
By strategically engaging with these pharmaceutical clusters, companies can optimize their supply chains for magnesium-based pharmaceutical products, enhancing both efficiency and market competitiveness.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Magnesium exporters from India
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's sells 14 ANDAs to Senores Pharmaceuticals
Dr. Reddy's Laboratories Ltd. entered into an agreement to sell 14 Abbreviated New Drug Applications (ANDAs) to Senores Pharmaceuticals. The portfolio includes 13 USFDA-approved applications and one pending approval. - IMPACT: This divestiture may allow Dr. Reddy's to reallocate resources, potentially affecting its magnesium export operations.
Impact: This divestiture may allow Dr. Reddy's to reallocate resources, potentially affecting its magnesium export operations.
Sun Pharmaceutical Industries Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Biocon Pharma Limited — WHO endorses GLP-1 therapies for obesity treatment
The World Health Organization released its first guideline endorsing Glucagon-like Peptide-1 (GLP-1) therapies for long-term obesity treatment in adults. - IMPACT: This endorsement may lead to increased demand for GLP-1 therapies, potentially influencing the production focus of these companies and impacting magnesium export volumes.
Impact: This endorsement may lead to increased demand for GLP-1 therapies, potentially influencing the production focus of these companies and impacting magnesium export volumes.
Cipla Limited, Annora Pharma Private Limited — Cipla and Annora Pharma win bids in China's VBP tender
Cipla Limited and Annora Pharma Private Limited secured bids to supply generic medicines to Chinese public hospitals under China's latest volume-based procurement (VBP) tender. - IMPACT: Participation in China's VBP tender may diversify revenue streams, potentially affecting the focus on magnesium exports.
Impact: Participation in China's VBP tender may diversify revenue streams, potentially affecting the focus on magnesium exports.
Common Questions — Magnesium Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which magnesium supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 1,459 recorded shipments worth $185.0M. CIPLA LIMITED (440 shipments) and DR.REDDY'S LABORATORIES LTD (228 shipments) are also established high-volume exporters.
Q How many magnesium manufacturers are there in India?
India has 669 active magnesium exporters with a combined export market of $361.3M across 8,413 shipments to 149 countries. The top 5 suppliers hold 76.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for magnesium from India?
Average FOB unit price: $7.33 per unit, ranging from $0.00 to $6924.17. Average shipment value: $42.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 669 verified Indian exporters of Magnesium ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 8,413 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 149 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,413 Verified Shipments
669 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists